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ORIGINAL ARTICLE
It has been estimated that up to 0.2 billion peo-
ple use illicit drugs worldwide, and among them
13.2 million inject drugs.1 Injection drug users
(IDUs), directly or indirectly, account for nearly
half of the annual human immunodeficiency virus
(HIV) infections in the United States.2 In South
and Southeastern Asia, there are 1.3–5.3 million
IDUs, and several countries, like China, Indonesia,
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Background/Purpose: Injection drug users (IDUs) have become the major contributors to the human 
immunodeficiency virus (HIV)/acquired immunodeficiency syndrome epidemic in Taiwan, accounting
for more than 60% of new cases in 2005. In Taiwan, gender difference in risk factors for HIV among IDUs
has not been reported before. We studied the clinical and sociodemographic characteristics, sexual behaviors,
drug use histories and criminal records of male and female HIV-infected IDUs.
Methods: A total of 100 male and 25 female HIV-infected inmates from two prisons were included. An in-
dividually structured interview was conducted with each inmate. Serostatus of hepatitis B virus (HBV) and
hepatitis C virus (HCV) were tested. CD4+ T cell count and HIV viral load were also evaluated.
Results: The mean age of the HIV-infected inmates was 31.7 ± 6.4 years. All inmates were co-infected with
HCV and 20% were HBV carriers. The mean CD4+ T cell count was 498 cells/µL, and the mean viral load
was 20,119 copies/mL. Heroin use history averaged 6.3 ± 5.1 years, and 84.8% of patients had a previous
criminal offense prior to current conviction. Female inmates were significantly younger, had more sexual
partners, had more drug-using family members or sexual partners, shared injection paraphernalia more
frequently, and started using methamphetamine and heroin at younger ages (p < 0.05). Male inmates
tended to be single, had less parental support, had been more frequently convicted of non drug-related
crimes, started using non-illicit substances more frequently at younger ages and had sex with prostitutes
more frequently (p < 0.05).
Conclusion: The results of this study suggest that drug injection risks and sexual behavior related risks 
are equally important in determining the risk of HIV infection among IDUs. Gender-specific approaches
to prevention which reflect differences in gender-related patterns of risk are also needed. [J Formos Med
Assoc 2007;106(6):467–474]
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Vietnam, Malaysia, Myanmar and Thailand, have
experienced HIV/acquired immunodeficiency syn-
drome (AIDS) epidemics driven by unsafe drug-
injection practices in recent years,1,3 accounting
for 30–90% of all reported infections in these
countries.
In Taiwan, since the HIV/AIDS epidemic began
in the early 1980s, heterosexual men and homo-
sexual men comprised the vast majority of the
HIV-infected population until 2004. Then, the
proportion of newly diagnosed HIV-infected cases
attributed to IDUs increased drastically, from
<10% in 2003 up to >60% in 2005.4 In December
2005, there were more than 10,000 reported HIV-
infected patients in Taiwan. Among them, one
third were IDUs.
Illicit drug users tend to have multiple HIV risk
factors, often including contaminated injection,
unprotected sex, tattooing and trading sex in ex-
change for drugs.5–7 Furthermore, illicit drug users
are often incarcerated for drug-related offenses, and
the “war on drugs” action by the Ministry of Justice
has resulted in greater numbers of illicit drug
users being sentenced,8,9 which has made IDUs or
drug-using inmates more difficult to follow up.
This may help to explain why there is limited 
reported data on the risks of HIV infection in
IDUs which have contributed to the outbreak
that is significantly impacting both individual
and community health.9
Strathdee et al10 reported that risk factors 
for HIV seroconversion differed markedly by sex.
Less than a high school education, recent needle
sharing with multiple partners, daily injection and
shooting-gallery attendance were risk factors for
HIV infection in male IDUs. Among females, 
factors consistent with high-risk sexual activity
were more significant than drug-related risks. 
In Taiwan, gender difference in risk factors for
HIV among IDUs has not been reported before.
Therefore, further study is urgently needed to 
determine the risk factors, such as sociode-
mographic characteristics, sexual behavior, drug
use history and criminal behavior patterns of




A total of 100 male and 25 female HIV-infected
inmates of two prisons (Taoyuan Prison and
Taoyuan Women’s Prison) were consecutively
enrolled. Eligible male and female inmates 
were recruited in a proportion of 4:1, because
the ratio of male to female drug offense en-
trants into prisons was around 4:1 in previous
data and during the study period.9 Informed
consent was obtained from each inmate before
the interview. The study was approved by the
committee on human research of the study 
institution.
Data collection
A structured interview was conducted with each
subject in private by a trained staff. Demographic
characteristics gathered included age, sex, eth-
nicity, family and marital status. Medical history
assessed included prior blood donation and
transfusion, hepatitis, bacterial infection and
trauma history. Behavioral variables assessed 
included age at initiation of substance use, fre-
quency of sharing equipment, number of drug
partners, number of sexual partners, condom
usage and whether they had had sex with prosti-
tutes. Drug use history and prior detention were
also analyzed.
Laboratory methods
All inmates with confirmed HIV infection 
underwent tests for hepatitis B virus (HBV) sur-
face antigen (HBsAg), hepatitis C virus (HCV)
antibody, CD4+ T cell count, and HIV viral 
load. HBsAg and antibodies to HCV were 
tested by the microparticle enzyme immuno-
assay method (Abbott Diagnostic Division, IL,
USA). CD4+ T cell count was measured by flow
cytometry (Epics XL; Beckman Coulter, Marseille,
France). HIV viral load was determined by re-
verse transcriptase–polymerase chain reaction
(RT-PCR Amplicor HIV-1 monitor test; Roche,
Branchburg, NJ, USA). The detection limit was
50 copies/mL.
Statistical analyses
Data were presented as mean ± standard deviation
for continuous variables and as a percentile for
discrete variables. Between-gender comparisons of
demographic factors, injection behavior and sex-
ual activities were conducted using Fisher’s exact
test for 2 × 2 comparison, χ2 test for 2 × 3 or more
comparison. We applied Mann–Whitney U test
for comparison of continuous variable, which was
non-parametric in this study. A p value < 0.05 was
considered statistically significant.
Results
The mean age of the HIV-infected inmates was
31.7 ± 6.4 years. Females were younger than males
(28.6 ± 5.2 vs. 32.5 ± 6.5 years, p < 0.05). The pre-
dominant ethnicities were Taiwanese (54%) and
Hakka (21%).
All of the HIV-infected inmates had HCV infec-
tion (i.e. HCV antibody positive) and 20% had
chronic HBV infection (i.e. HBsAg positive). The
mean CD4+ T cell count was 498 ± 170 cells/µL
(range, 140–920 cells/µL; only three inmates had
CD4+ T cell count < 200 cells/µL). The mean viral
load was 20,119 ± 21,564 copies/mL (range, 50
to > 100,000 copies/mL).
Less than half (44%) of the inmates had at-
tended high school, and 24.8% were unemployed
before incarceration. Male inmates had a higher
frequency of incomplete parental support during
childhood (one or both parents died) compared to
females (49% vs. 24%, p < 0.05). Forty-five percent
of our inmates had a current or previous marriage
(male to female, 39% vs. 68%, p < 0.05), and most
of them (61%) were now separated or divorced.
More women had family members or sexual part-
ners who also used illicit drugs than men (44%
vs. 23%, p < 0.05) (Table 1).
Analysis of data on injection-related medical
history revealed that accidental trauma (29%) and
hepatitis (18%) were commonly encountered ill-
nesses, especially in males (Table 1). Blood dona-
tion was reported in 25% of inmates, and six (20%)
of these inmates had continued to donate blood
even during the period of heroin use. Chronic 
illness, such as hypertension, was only reported
by four patients (3.2%) (Table 1).
A previous criminal offense prior to their cur-
rent conviction was recorded for 84.8% of in-
mates. Drug offense (72%) and larceny (24%)
were the most common convictions. Male inmates
had often been convicted of crimes other than
drug offense (Table 1).
All of the HIV-infected inmates were IDUs and
heroin users. The median age at the time of start-
ing illicit drug use was 20 years old (range, 10–42
years). The heroin use history averaged 6.3 ± 5.1
years. The median monthly expenditure for drugs
was US$1860 (range, 44–8912), i.e. NT$63,200
(range, 1500–303,000). Seventy-four percent of
inmates had never visited a drug treatment clinic
or been admitted to a hospital for substance abuse
therapy. The most commonly used methods for
self detoxification were directly stopping substance
use (cold turkey detoxification) and trying to en-
dure the withdrawal period at home (56%), with
or without using over-the-counter medication. The
typical reported sequence of initiating substance
use for males was smoking, drinking, chewing
betel nut, and finally exposure to methamphet-
amine and heroin. Male inmates tended to use
readily available drugs (alcohol and betel nut)
more frequently (44% vs. 12% and 29% vs. 0%,
p < 0.05) and at younger ages (14 vs. 15 years,
p < 0.05) than females. Female inmates, however,
started illicit drug use (methamphetamine and
heroin) earlier than males (16 vs. 18 years and 21 vs.
25 years, p < 0.05) (Table 2).
Women were less likely to have had a monog-
amous sexual partner (12% vs. 42%, p < 0.05).
Having sex with prostitutes and casual sex were
more common in males (43% vs. 20%, p < 0.05).
Overall, two thirds (60%) of the inmates reported
not using condoms during sex (Table 3).
The majority of the inmates reported having
used injection equipment that had already been
used by others. Women reported more frequent
sharing of paraphernalia such as rinse water (fe-
male vs. male, 68% vs. 37%, p < 0.05) (Table 3).
Nine tenths of the inmates had two to five drug
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partners, and 6% had more than five drug part-
ners. Only five patients (4%) denied any practice
of sharing injection equipment.
Discussion
This study analyzed the characteristics of HIV-
infected incarcerated IDUs. The high CD4+ T cell
count and low HIV viral load implied that these
inmates were in the early stage of HIV infection.11
The high prevalence of HCV infection in IDUs 
is consistent with the findings of previous stud-
ies.12,13 Many of our subjects reported a previous
history of hepatitis. The above findings suggest
that HCV commonly occurs prior to their HIV
infection in IDUs. The HBV carrier rate of 20%
among the HIV-infected inmates in this study is
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Table 1. Demographic and clinical characteristics of human immunodeficiency virus-infected injection drug
users incarcerated in prisons
Total Men Women 
p*
(n = 125) (n = 100) (n = 25)
Age (mean ± SD) 31.7 ± 6.4 32.5 ± 6.5 28.6 ± 5.2 < 0.05
Education (yr)
≤ 6 9% 8% 24%
7–9 48% 49% 44%
≥ 10 44% 43% 44%
Marital status < 0.05
Single 55% 61% 32%
Married 18.4% 15% 28%
Separated/divorced 27% 24% 40%
Inadequate parental support 44% 49% 24% < 0.05
Drug use of family/sexual partner 27.2% 23% 44% < 0.05
Occupational status
Unemployed 24.8% 23% 32%
Employed 75.2% 77% 68%
Labor 66% 75% 24% < 0.05
Business 15% 14% 18%
Services 19% 10% 59%
Drug-related medical history
Hepatitis 14% 18% 0% < 0.05
Injection complications† 3.2% 1% 12% < 0.05
Traumatic accident‡ 25% 29% 8% < 0.05
Blood donation 24.8% 26% 20%
Blood transfusion 11.2% 12% 8%
Previous conviction 84.8% 88% 72%
Drug offense 72% 72% 72%
Drug dealing 7% 9% 0%
Drug use 68% 67% 72%
Non-drug offense 51.2% 60% 16% < 0.05
Larceny 24% 28% 8% < 0.05
Weapon possession 12.8% 16% 0% < 0.05
Assault§ 14% 18% 0% < 0.05
Robbery 10% 12% 0% < 0.05
*Fisher’s exact test, χ2 test or Mann–Whitney U test; †including bacteremia, endocarditis and cellulitis; ‡including fractures, internal
bleeding and sharp wounds, etc.; §including insult, kidnapping, homicide, infringement on freedom and sexual assault. SD =
standard deviation.
similar to the 15–20% rate reported for the adult
population in Taiwan.14 This might be due to the
fact that 90% of adults have been infected with
HBV in Taiwan, and most of the HBsAg carriers
acquired the infection via vertical transmission.15
Although most of our patients reported shar-
ing needles and syringes, they shared injection
paraphernalia more frequently, especially the water
used to rinse injection equipment and dilute the
drugs. Sharing of this rinse water might thus be
an important risk of HIV infection among IDUs
in Taiwan, although reports from other countries
found that sharing of syringes, needles, and shoot-
ing gallery were major risk factors but did not
emphasize such an association for rinse water.10,16
Research on needle exchange programs or
methadone maintenance therapy has often concen-
trated on the effect of injection-risk reduction.16–18
However, several studies have shown that sexual
risks are strongly associated with HIV seroconver-
sion in IDUs.6,7,10 This study also found that prac-
tices of unprotected sex, including multiple sexual
partners, prostitution and reluctance to use con-
doms were common in HIV-infected IDUs. There-
fore, in terms of public health, knowledge and
methods for sexual risk reduction should be fur-
ther emphasized in educational programs.
Nine tenths of the HIV-infected IDU inmates
in this study were ex-convicts. Previous studies
have confirmed a strong correlation between drug
abuse and crime, and the substantial economic
and constitutional costs to society are immense.19
Amphetamine and heroin were the most preva-
lent illegal substances used by the inmates in this
study. Unfortunately, less than one third of the
inmates had previously attended a drug treatment
program. Criminal penalties related to drug use
might have hindered some drug users from seek-
ing outside help. In addition, inadequate family
support and educational level below the norm
might also have contributed to this problem.
Greater availability of a wider variety of treatment
modalities and outreach to provide detoxification
services are urgently needed in Taiwan.
Male HIV-infected IDUs in this study almost
universally began smoking (100%), drinking 
alcohol (44%), and chewing betel nut (29%) in
adolescence. This finding suggests the need for
greater attention to substance abuse education for
teenagers in Taiwan. In the United States, many
Gender difference in HIV-infected IDUs
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Median (range) Median (range)
Tobacco 100 14† (9–27) 100 15 (12–24)
Alcohol 44* 15 (5–25) 12 17 (15–20)
Betel nut 29* 15 (10–25) 0 – –
Sedatives 2 27.5 (25–30) 0 – –
Glue 3 14 (10–15) 0 – –
MDMA 2 23 (21–25) 8 20.5 (20–21)
Marijuana 2 18 (18–18) 8 20.5 (20–21)
Methamphetamine 78 18 (10–42) 96 16† (11–30)
Heroin 100 25 (12–45) 100 21† (16–30)
Age at first use of a 14† (5–27) 15 (12–24)
readily available drug‡
Age at first use of an 20 (10–42) 16† (11–30)
illicit drug§
*p < 0.05, Fisher’s exact test for substance-use prevalence; †p < 0.05, Mann–Whitney U test for onset age of each substance; ‡readily
available drugs: tobacco, alcohol, betel nut; §illicit drugs: sedatives, glue, MDMA, marijuana, methamphetamine, heroin. MDMA =
3,4-methylenedioxymethamphetamine.
school-based drug abuse prevention programs,
such as Drug Abuse Resistance Education (DARE),
have been widely adopted, but their long-term
effectiveness remains questionable.20,21 How to in-
tegrate the school-, household-, community-, and
healthcare setting-prevention curricula for adoles-
cent substance use to maximize its effectiveness,
however, is a great challenge.
All female HIV-infected IDUs in this study were
of childbearing age, and therefore needed special
attention to related issues. Women, often under
the influence of family members or sexual part-
ners, began illicit drug use at a younger age, and
also frequently had unprotected sex and risky 
injection practices. Our results indicate the implicit
overlaps between sexual partners and drug use
partners among female IDUs.22 The need for cou-
ple counseling and woman-controlled barriers
should be taken into account in the development
of adequate prevention programs.
Our study had several important limitations.
First, the recruited subjects were prison inmates,
instead of being recruited from the community,
where IDUs typically conceal their behavior to
avoid law enforcement. The study sample might
therefore not be representative of the general IDU
population. Second, the low percentage of homo-
sexual subjects in this sample was regarded as due
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Table 3. Sexual behavior and patterns of injection in human immunodeficiency virus-infected injection drug
users incarcerated in prisons stratified by gender
Male (n = 100) Female (n = 25) p
Number of sexual partners 0.031*
1 42% 12%
2–3 23% 44%
> 3 35% 44%
Frequency of condom usage 1.0
100% 9% 8%
> 50% 15% 12%
< 50% 17% 16%
0% 59% 64%
Prostitution and casual sex 43% 20% 0.04*
Homosexuality 2% 4% 0.60
Receivers of syringes 0.951
Always 3% 4%
> 50% 11% 12%
< 50% 66% 60%
Never 20% 24%
Givers of syringes 0.472
Always 3% 4%
> 50% 12% 24%
< 50% 40% 36%
Never 45% 36%
Sharing of rinse water 0.049*
Always 37% 68%
> 50% 16% 8%
< 50% 30% 16%
Never 17% 8%
*p < 0.05, Fisher’s exact test or χ2 test conducted for gender difference.
to under-reporting, which was likely contributed
to by societal stigmatization. Third, there might
be some bias in the use of self-reported data.
However, a multicenter survey showed that self-
reporting was very reliable among drug users.23
Due to the difficulty of approaching illicit drug
users in general circumstances in the community
and their frequent incarceration, jails and prisons
are important settings for education and health
promotion to prevent HIV infection in this sub-
population. The results of this study strongly sug-
gest that injection risks and sexual behavior risks
are equally important to the risk of HIV infection
in the IDU population in Taiwan. In the campaign
against the HIV epidemic driven by IDUs, preven-
tion strategies must adequately address both these
factors.
Currently, harm reduction programs, including
needle exchange and methadone replacement
therapy, are being disseminated in Taiwan. Expe-
rienced countries have shown the effectiveness 
of such programs to prevent further substance
abuse in IDUs and reduce the risk of HIV 
infection.10,16–18,24 We suggest gender-specific
approaches to prevention that reflect the differ-
ences in gender-related patterns of risk.
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